Comparing Proteomics and RISC Immunoprecipitations to Identify Targets of Epstein-Barr Viral miRNAs

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kuzembayeva, Malika ^a   Chiu, Ya Fang ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MICRORNA; VIRUS RNA;

ARTICLE; EPSTEIN BARR VIRUS; EXON; GENE CONTROL; GENE EXPRESSION; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEOMICS; SEQUENCE ANALYSIS; VIRUS GENE;

CELL LINE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPRECIPITATION; MICRORNAS; PROTEIN BINDING; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; RNA-INDUCED SILENCING COMPLEX;

EID: 84867586283     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047409     Document Type: Article

References (29)

1. Bernstein E, Kim SY, Carmell MA, Murchison EP, et al. (2003) Dicer is essential for mouse development. Nat Genet 35: 215-217.
2. Chen CZ, (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771.
3. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 9: 597-610.
4. Thomson DW, Bracken C, Goodall GJ, (2011) Experimental strategies for microRNA target identification. Nucleic Acids Res 39: 6845-6853.
5. Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734-6.
6. Dar W, Sugden B. (2010) Epstein-Barr Virus as a Pathogen. In: Khalili K, Jeang KT, editors. Viral Oncology: Basic Science and Clinical Applications, Chapter 21, 425-452. New Jersey: Wiley-Blackwell, 425-452.
7. Young LS, Murray PG, (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108-21.
8. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-68.
9. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B, (2009) The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386: 387-397.
10. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666-75.
11. Lo AK, To KF, Lo KW, Lung RW, Hui JW, (2007) Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A 104: 16164-16169.
12. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J., doi:10.1038/emboj.2012.63.
13. Choy EY, Siu KL, (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551-2560.
14. Seto E, Moosmann A, Grömminger S, Walz N, Grundhoff A, et al. (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathogens 6: e1001063.
15. Dölken L, Malterer G, Erhard F, Kothe S, Friedel CC, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7: 324-34.
16. Skalsky R, Corcoran D, Gottwein E, Frank C, Kang D, et al. (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathogens 8: e1002484.
17. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
18. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
19. Walz N, Christalla T, Tessmer U, Grundhoff A, (2010) A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs. J Virol 84: 716-28.
20. Schramedei K, Mörbt N, Pfeifer G, Läuter J, Rosolowski M, et al. (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30: 2975-85.
21. Zhu S, Si ML, Wu H, Mo YY, (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-36.
22. Klein G, Lindahl T, Jondal M, Leibold W, Menézes J, et al. (1974) Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A 7: 3283-3286.
23. Vollrath AL, Smith AA, Craven M, Bradfield CA, (2009) EDGE(3): a web-based solution for management and analysis of Agilent two color microarray experiments. BMC Bioinformatics 10: 280.
24. Rüdel S, Flatley A, Weinmann L, Kremmer E, Meister G, (2008) A multifunctional human Argonaute2-specific monoclonal antibody. RNA 6: 1244-2153.
25. Marouga R, David S, Hawkins E, (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669-78.
26. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nature Genet 39: 1278-1284.
27. Darnell R, (2010) HITS-CLIP: panoramic views of protein-RNA regulation in living cells. Wiley Interdiscip Rev RNA 1: 266-286.
28. Roush S, Slack FJ, (2008) The let-7 family of miRNAs. Trends cell biol 18: 505-16.
29. Witkos TM, Koscianska E, Krzyzosiak WJ, (2011) Practical Aspects of microRNA Target Prediction. Curr Mol Med 11: 93-109.